Market Tracker

05/25 4:45pm ET

Regulus Therapeutics Inc (NASDAQ:RGLS)

5.86
Delayed Data
As of May 25
 +0.01 / +0.17%
Today’s Change
4.96
Today|||52-Week Range
14.44
-32.80%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close5.85
Today’s open5.89
Day’s range5.82 - 6.03
Volume616,624
Average volume (3 months)834,632
Market cap$308.8M
Dividend yield--
Data as of 4:00pm ET, 05/25/2016

Growth & Valuation

Earnings growth (last year)+16.28%
Earnings growth (this year)-42.48%
Earnings growth (next 5 years)--
Revenue growth (last year)+170.69%
P/E ratioNM
Price/Sales21.60
Price/Book2.48

Competitors

 Today’s
change
Today’s
% change
NLNKNewLink Genetics Cor...+0.28+2.57%
TLGTTeligent Inc+0.01+0.17%
GALEGalena Biopharma Inc-0.02-1.15%
CNCEConcert Pharmaceutic...+0.07+0.53%
Data as of 4:00pm ET, 05/25/2016

Financials

Next reporting dateAugust 9, 2016
EPS forecast (this quarter)-$0.39
Annual revenue (last year)$20.8M
Annual profit (last year)-$55.7M
Net profit margin-268.55%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Paul C. Grint
COO, Principal Financial &
Accounting Officer
Joseph P. Hagan
Corporate headquarters
San Diego, California

Forecasts